FOXM1 was reported to be upregulated in lung cancer (including NSCLC) and was associated with poor prognosis of patients, as well as regulating cell proliferation, apoptosis, and metastasis of cancer cells [36,37]. Here, FOXM1 is linked to lung carcinoma.